These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 22846869)

  • 1. Locally advanced pancreatic cancer.
    Auriemma WS; Berger AC; Bar-Ad V; Boland PM; Cohen SJ; Roche-Lima CM; Morris GJ
    Semin Oncol; 2012 Aug; 39(4):e9-22. PubMed ID: 22846869
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies.
    Mehta J; Prabhu R; Eshpuniyani P; Kantharia C; Supe A
    Trop Gastroenterol; 2010; 31(3):190-4. PubMed ID: 21560524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pancreatic lymphoma: a clinical quandary of diagnosis and treatment.
    Du X; Zhao Y; Zhang T; Liao Q; Dai M; Liu Z; Guo J; Hu Y
    Pancreas; 2011 Jan; 40(1):30-6. PubMed ID: 20683215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer.
    Seo Y; Kim MS; Yoo S; Cho C; Yang K; Yoo H; Choi C; Lee D; Kim J; Kim MS; Kang H; Kim Y
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1456-61. PubMed ID: 19783379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
    Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
    Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients].
    Grinbaum R; Nissan A; Beglaibter N; Cohen T; Peretz T; Freund HR
    Harefuah; 2006 Nov; 145(11):793-4, 863. PubMed ID: 17183947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
    Clark CJ; Traverso LW
    Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic cancer screening: mission impossible?].
    Bartel M; Friess H
    Z Gastroenterol; 2006 Nov; 44(11):1181-2. PubMed ID: 17115361
    [No Abstract]   [Full Text] [Related]  

  • 9. Early diagnosis of pancreatic cancer.
    Furukawa H; Okada S; Kakizoe T
    Hepatogastroenterology; 1999; 46(25):4-7. PubMed ID: 10228757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
    Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
    J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A difficult early diagnosis of pancreatic body neoplasia.
    Boldrini E; Cristani A; Cioni G; Roccato S; De Santis M; Bonilauri S; Berselli T; Melotti G
    Hepatogastroenterology; 1996; 43(9):730-3. PubMed ID: 8799421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers for pancreatic cancer: what happens when preoperative CA 19-9 is undetectable?
    Bouvet M
    Ann Surg Oncol; 2004 Jul; 11(7):637-8. PubMed ID: 15197009
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreaticoduodenectomy for chronic pancreatitis: a case report and literature review.
    Riker A; Bartlett D
    Hepatogastroenterology; 1999; 46(27):2005-10. PubMed ID: 10430385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
    Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
    Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic left pancreatectomy for pancreatic solid pseudopapillary tumor.
    Ntourakis D; Marzano E; De Blasi V; Oussoultzoglou E; Jaeck D; Pessaux P
    Ann Surg Oncol; 2011 Mar; 18(3):642-3. PubMed ID: 21088915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.
    Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR
    J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA19-9 determination in the management of pancreatic cancer.
    van den Bosch RP; van Eijck CH; Mulder PG; Jeekel J
    Hepatogastroenterology; 1996; 43(9):710-3. PubMed ID: 8799418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
    Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
    Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer.
    Ishii H; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S
    Hepatogastroenterology; 1997; 44(13):279-83. PubMed ID: 9058159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two successful curative operations using stomach-preserving distal pancreatectomy with celiac axis resection for the treatment of locally advanced pancreatic body cancer.
    Mizutani S; Shioya T; Maejima K; Komine O; Yoshino M; Hoshino A; Ogata M; Watanabe M; Yanagimoto K; Shibuya T; Tokunaga A; Tajiri T
    J Hepatobiliary Pancreat Surg; 2009; 16(2):229-33. PubMed ID: 19224117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.